RAD001 (EVEROLIMUS)
Showing 1 - 25 of 1,022
Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))
Active, not recruiting
- Endometrial Cancer
- Letrozole
- RAD001 (Everolimus)
-
Morristown, New Jersey
- +1 more
Nov 16, 2022
Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)
Active, not recruiting
- Neurofibromatosis Type 2
- Neuroma, Acoustic
- RAD001, everolimus
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Mar 2, 2022
Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)
Completed
- Breast Cancer
- Neoplasm Metastasis
-
Houston, TexasUT MD Anderson Cancer Center
Sep 30, 2022
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)
Not yet recruiting
- Metastatic Midgut Neuroendocrine Tumor
- Unresectable Midgut Neuroendocrine Tumor
- Biospecimen Collection
- +5 more
- (no location specified)
Mar 16, 2023
Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)
Active, not recruiting
- Advanced Cancers
- Solid Tumors
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)
Completed
- Solid Organ Malignancies
- +2 more
-
Atlanta, Georgia
- +1 more
Nov 19, 2021
Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 16, 2021
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022
PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome Trial in Palo Alto, Boston, Cleveland (RAD001, Placebo)
Completed
- PTEN Gene Mutation
- PTEN Hamartoma Tumor Syndrome
- RAD001
- Placebo
-
Palo Alto, California
- +2 more
Feb 7, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast Cancer Trial in Israel (Everolimus,
Completed
- Postmenopausal Women
- +2 more
-
Jerusalem, Israel
- +6 more
Mar 25, 2021
Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,
Terminated
- Low Grade Glioma
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 3, 2021
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)
Suspended
- Thyroid Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2022
Lymphangioleiomyomatosis Trial in France, Italy, United States (Everolimus)
Completed
- Lymphangioleiomyomatosis
-
Boston, Massachusetts
- +3 more
Nov 16, 2020
Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,
Recruiting
- Advanced Lung Carcinoid Tumor
- +11 more
- Everolimus
- Lutetium Lu 177 Dotatate
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena
Completed
- Estrogen Receptor Negative
- +4 more
- everolimus
- +3 more
-
Duarte, California
- +2 more
Jun 6, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022